BIVI
Income statement / Annual
Last year (2024), BioVie Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, BioVie Inc.'s net income was -$32.12 M.
See BioVie Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
Period Ended |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
06/30/2016 |
06/30/2015 |
Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Cost of Revenue |
$229,377.00
|
$266,842.00
|
$237,421.00
|
$229,377.00
|
$229,377.00
|
$229,377.00
|
$229,377.00
|
$229,377.00
|
$51,036.00
|
$0.00
|
Gross Profit |
-$229,377.00
|
-$266,842.00
|
-$237,421.00
|
-$229,377.00
|
-$229,377.00
|
-$229,377.00
|
-$229,377.00
|
-$229,377.00
|
-$51,036.00
|
$0.00
|
Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
Research and Development Expenses |
$23.10 M
|
$33.30 M
|
$17.26 M
|
$133.19 M
|
$1.15 M
|
$1.01 M
|
$370,853.00
|
$466,354.00
|
$37,901.00
|
$4,196.00
|
General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.26 M
|
$1.77 M
|
$857,883.00
|
$343,091.00
|
$229,181.00
|
Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$8.85 M
|
$11.55 M
|
$9.77 M
|
$4.64 M
|
$1.31 M
|
$1.26 M
|
$1.77 M
|
$857,883.00
|
$343,091.00
|
$229,181.00
|
Other Expenses |
$0.00
|
$229.38 M
|
$229,377.00
|
$229,377.00
|
$229,377.00
|
$229,377.00
|
$229,377.00
|
$229,377.00
|
$51,036.00
|
$212,710.00
|
Operating Expenses |
$31.95 M
|
$45.08 M
|
$27.25 M
|
$138.05 M
|
$2.69 M
|
$2.50 M
|
$2.37 M
|
$1.55 M
|
$432,028.00
|
$233,377.00
|
Cost And Expenses |
$32.18 M
|
$45.08 M
|
$27.25 M
|
$138.05 M
|
$2.69 M
|
$2.50 M
|
$2.37 M
|
$1.55 M
|
$432,028.00
|
$233,377.00
|
Interest Income |
$1.14 M
|
$562,264.00
|
$44,080.00
|
$21,971.00
|
$234.00
|
$1,159.00
|
$4.00
|
$14.00
|
$186.00
|
$369.00
|
Interest Expense |
$2.89 M
|
$4.30 M
|
$2.16 M
|
$559,455.00
|
$4.77 M
|
$273.00
|
$40,960.00
|
$0.00
|
$81.00
|
$0.00
|
Depreciation & Amortization |
$229,377.00
|
$266,842.00
|
$237,421.00
|
$229,377.00
|
$229,377.00
|
$229,377.00
|
$229,377.00
|
$229,377.00
|
$51,036.00
|
$369.00
|
EBITDA |
-$31.95 M |
-$45.69 M |
-$23.68 M |
-$137.80 M |
-$2.46 M |
-$2.27 M |
-$2.14 M |
-$1.32 M |
-$380,806.00 |
-$233,008.00 |
EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
Total Other Income/Expenses Net |
$59,052.00
|
-$5.18 M
|
$1.17 M
|
$7.80 M
|
-$13.98 M
|
$52,286.00
|
-$40,956.00
|
$222,942.00
|
$105.00
|
$369.00
|
Income Before Tax |
-$32.12 M
|
-$50.26 M
|
-$26.08 M
|
-$130.25 M
|
-$16.68 M
|
-$2.44 M
|
-$2.41 M
|
-$1.33 M
|
-$431,923.00
|
-$233,008.00
|
Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
Income Tax Expense |
$0.00
|
$4.30 M
|
-$3.29 M
|
$559,455.00
|
$4.77 M
|
-$51,400.00
|
-$1.00
|
-$222,928.00
|
-$105.00
|
-$369.00
|
Net Income |
-$32.12 M
|
-$50.26 M
|
-$26.08 M
|
-$183.85 M
|
-$33.78 M
|
-$2.49 M
|
-$2.43 M
|
-$1.33 M
|
-$431,923.00
|
-$233,008.00
|
Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
EPS |
-3.555 |
-7.735 |
-5.29 |
-74.115 |
-34.26 |
-4.91 |
-15.885 |
-9.305 |
-3.095 |
-1.67 |
EPS Diluted |
-3.555 |
-7.735 |
-5.29 |
-74.115 |
-34.26 |
-4.91 |
-15.885 |
-9.305 |
-3.095 |
-1.67 |
Weighted Average Shares Out |
$9.04 M
|
$6.50 M
|
$4.93 M
|
$2.48 M
|
$985,898.00
|
$507,922.00
|
$153,212.00
|
$143,026.00
|
$139,518.00
|
$139,536.00
|
Weighted Average Shares Out Diluted |
$9.04 M
|
$6.50 M
|
$4.93 M
|
$2.48 M
|
$985,898.00
|
$507,922.00
|
$153,212.00
|
$143,026.00
|
$139,518.00
|
$139,536.00
|
Link |
|
|
|
|
|
|
|
|
|
|